EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Juvenile Paget’s disease in two Chinese pedigrees carrying distinct novel homozygous TNFRSF11B variants: clinical manifestations, management, and follow-up

Xinyu Qian, Zhiyang Wu, Qi Lu, Xi Chen, Yier Fan, Ke Deng, Shanshan Li, Hua Yue, Zhenlin Zhang

Osteoporosis International · 12.11.2026

DOI: 10.1007/s00198-026-08299-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoporosis International, online erschienen am 12.11.2026. Verfasst von Xinyu Qian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Osteoporosis and Bone Disease, Shanghai Clinical Research Center of Bone Disease, Shanghai Jiao Tong University Affiliated Sixth People…. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Transform Program, National Major Science and Technology Projects of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Juvenile Paget's disease (JPD) is an ultra-rare autosomal recessive skeletal disorder caused by loss-of-function mutations in TNFRSF11B, which encodes osteoprotegerin (OPG), resulting in enhanced osteoclastic bone resorption. PURPOSE: To describe the clinical, genetic, and therapeutic features of two patients with a clinical diagnosis of JPD who carried distinct homozygous TNFRSF11B variants. METHODS: Clinical and longitudinal follow-up analyses of two unrelated Chinese pedigrees with JPD were performed. Clinical assessment, biochemical testing, skeletal imaging, Sanger sequencing of TNFRSF11B with familial segregation, in silico pathogenicity prediction, and AlphaFold-based structural analysis were undertaken. RESULTS: Patient 1 (P1), a 3-year-old boy, had severe early-onset disease with recurrent fractures, macrocephaly, long-bone bowing, markedly elevated bone turnover markers, and diffuse skeletal involvement on imaging. Patient 2 (P2), a 35-year-old woman, had a milder but progressive deforming phenotype with scoliosis, profound hearing loss, low lumbar spine bone mineral density (BMD), persistent biochemical hyperturnover, and extensive polyostotic skeletal disease on imaging. Sanger sequencing identified two novel homozygous TNFRSF11B missense variants: c.544 G > T (p. Asp182Tyr) in P1 and c.307 C > T (p. Arg103Cys) in P2; both families showed heterozygous parental carrier status. Both variants were classified as variants of uncertain significance (VUS) by the genetic testing laboratory. Zoledronic acid in P1 rapidly reduced alkaline phosphatase (ALP) from 5069 to 1917 U/L at 6 weeks and improved skeletal mineralization, but was complicated by hungry bone syndrome. Denosumab in P2 markedly suppressed bone turnover markers, reduced pain, improved mobility, prevented new fractures during the 1-year follow-up, and increased lumbar spine BMD by 17.5% at 6 months. CONCLUSION: This study expanded the genotypic and phenotypic spectrum of OPG-deficient JPD and confirmed that both zoledronic acid and denosumab were effective treatments, although response and safety differed according to age and baseline disease activity, supporting individualized antiresorptive management.

Schlagwörter

Stichwörter der Autor:innen

TNFRSF11BJuvenile Paget’s diseaseMutationsOsteoprotegerin

Autor:innen und Institutionen

  • Department of Osteoporosis and Bone Disease, Shanghai Clinical Research Center of Bone Disease, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Department of Bone Disease, Quanzhou Orthopedic-Traumatological Hospital, Fujian, China.
  • Department of Osteoporosis and Bone Disease, Shanghai Clinical Research Center of Bone Disease, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. yueyinglonghua@163.com.
  • Department of Osteoporosis and Bone Disease, Shanghai Clinical Research Center of Bone Disease, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. zzl2002@medmail.com.cn.

Förderung

  • National Key Transform Program
  • National Major Science and Technology Projects of China
  • National Natural Science Foundation of China

Zitieren

APA

Qian, X., Wu, Z., Lu, Q., Chen, X., Fan, Y., Deng, K., Li, S., Yue, H., & Zhang, Z. (2026). Juvenile Paget’s disease in two Chinese pedigrees carrying distinct novel homozygous TNFRSF11B variants: clinical manifestations, management, and follow-up. Osteoporosis International. https://doi.org/10.1007/s00198-026-08299-6

Vancouver

Qian X, Wu Z, Lu Q, Chen X, Fan Y, Deng K, et al. Juvenile Paget’s disease in two Chinese pedigrees carrying distinct novel homozygous TNFRSF11B variants: clinical manifestations, management, and follow-up. Osteoporosis International. 2026. doi:10.1007/s00198-026-08299-6

BibTeX
@article{Qian2026,
  author = {Qian, Xinyu and Wu, Zhiyang and Lu, Qi and Chen, Xi and Fan, Yier and Deng, Ke and Li, Shanshan and Yue, Hua and Zhang, Zhenlin},
  title = {Juvenile Paget’s disease in two Chinese pedigrees carrying distinct novel homozygous TNFRSF11B variants: clinical manifestations, management, and follow-up},
  journal = {Osteoporosis International},
  year = {2026},
  doi = {10.1007/s00198-026-08299-6}
}
Kostenlos starten →